AMNIOMATRIX® Human Amniotic Suspension Allograft
AMNIOMATRIX® is a cryopreserved liquid allograft derived from the components of the amniotic membrane and amniotic fluid that provides structural tissue to advance soft tissue repair, replacement and reconstruction.
• Maintains essential wound healing growth factors
• Fully resorbable
• Available in multiple sizes
AMNIOMATRIX® Human Amniotic Suspension Allograft is used in the treatment of acute and chronic wounds including, but not limited to: diabetic foot ulcers, venous leg ulcers, arterial ulcers, pressure ulcers, inflammatory ulcers, and burns.
AMNIOMATRIX® Human Amniotic Suspension Allograft should not be used in the presence of active infection or on patients with a known sensitivity to ethanol.
AMNIOMATRIX® Human Amniotic Suspension Allograft are suitable for transplantation in an unopened, undamaged package.
This allograft is intended for single use only. Discard any unused material.
Use is limited to specific health professionals (e.g. physicians).
Once the expiration date on the label has been reached, the allograft must be discarded.
Do not use if the package integrity has been violated, is opened or damaged, or if mishandling has caused possible damage or contamination.
Although donor tissue is evaluated and processed following strict FDA guidelines, the donor screening methods are limited and may not detect all diseases. As with any allograft, an absolute guarantee of tissue safety is not possible. This allograft has the potential to transmit infectious disease to the recipient.
AMNIOMATRIX® Human Amniotic Suspension Allograft should be stored at -60°C or below. Check the label for expiration.
|Shelf life greater than 2 years|
|Shelf life limited|
|Indicated for acute wounds||●|
|Indicated for chronic wounds||●|
|Indicated for diabetic ulcers||●|
|Indicated for pressure ulcers||●|
|Indicated for surgical wounds||●|
|Indicated for third-degree burns|
|Indicated for venous ulcers||●|
|Contact manufacturer for usage guidelines|
|Variety of sizes||●|
Moderate/Highly Exudating Wounds
Non/Minimally Exudating Wounds
Integra LifeSciences, a worldwide leader in regenerative medicine, is dedicated to improving the quality of life for patients through the development of cost-effective solutions used to treat millions of patients every year. With over two decades of clinical efficacy and a reputation for delivering quality, Integra's advanced wound care products are a premiere solution for clinicians.